Abstract
Background and importanceBictegravir (BIC), a second generation integrase strand transfer inhibitor, approved for HIV treatment in fixed dose combination with emtricitabine (FTC) and tenofovir alafenamide (TAF), has potent antiviral activity...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.